# Dapsone

NDC: 70771-1538
Generic name: Dapsone
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20240510

FDA application: ANDA214019

## Active ingredients

- DAPSONE: 75 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1538"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1538
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b63b653-0507-4f95-9bfa-70fd071e15a6